Cargando…
Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice
Over the past decade, there has been an increase in the number of clinical trials for psychedelic therapies as treatments for a wide range of psychiatric conditions. We are concerned that research organizations overseeing these trials have neglected the inclusion of individuals with physical and sen...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174510/ https://www.ncbi.nlm.nih.gov/pubmed/35693959 http://dx.doi.org/10.3389/fpsyt.2022.914458 |
_version_ | 1784722250629382144 |
---|---|
author | Mintz, Kevin T. Gammer, Brinn Khan, Amanda J. Shaub, Gretchen Levine, Steven Sisti, Dominic |
author_facet | Mintz, Kevin T. Gammer, Brinn Khan, Amanda J. Shaub, Gretchen Levine, Steven Sisti, Dominic |
author_sort | Mintz, Kevin T. |
collection | PubMed |
description | Over the past decade, there has been an increase in the number of clinical trials for psychedelic therapies as treatments for a wide range of psychiatric conditions. We are concerned that research organizations overseeing these trials have neglected the inclusion of individuals with physical and sensory disabilities. We suggest that psychedelic research organizations should prioritize and plan for the inclusion of individuals with physical and sensory disabilities to address the mental health burdens they confront. Not doing so risks reinforcing structural ableism in healthcare: the discriminatory manifestation of lowered expectations toward people with disabilities on the part of medical providers. Drawing on scholarship from disability studies and medical ethics, we offer four recommendations for disability inclusion in research. We recognize particular populations shoulder significant mental health burdens; these populations deserve priority and should be given a range of accommodations. We emphasize the need for extensive disability awareness training for those facilitating psychedelic therapies and encourage psychedelic researchers and therapists to exercise cultural humility toward individuals with physical and sensory disabilities. This article should be the impetus for further scholarship and debate about how psychedelic research and therapies can be made accessible to members of disability communities who might benefit. |
format | Online Article Text |
id | pubmed-9174510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91745102022-06-09 Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice Mintz, Kevin T. Gammer, Brinn Khan, Amanda J. Shaub, Gretchen Levine, Steven Sisti, Dominic Front Psychiatry Psychiatry Over the past decade, there has been an increase in the number of clinical trials for psychedelic therapies as treatments for a wide range of psychiatric conditions. We are concerned that research organizations overseeing these trials have neglected the inclusion of individuals with physical and sensory disabilities. We suggest that psychedelic research organizations should prioritize and plan for the inclusion of individuals with physical and sensory disabilities to address the mental health burdens they confront. Not doing so risks reinforcing structural ableism in healthcare: the discriminatory manifestation of lowered expectations toward people with disabilities on the part of medical providers. Drawing on scholarship from disability studies and medical ethics, we offer four recommendations for disability inclusion in research. We recognize particular populations shoulder significant mental health burdens; these populations deserve priority and should be given a range of accommodations. We emphasize the need for extensive disability awareness training for those facilitating psychedelic therapies and encourage psychedelic researchers and therapists to exercise cultural humility toward individuals with physical and sensory disabilities. This article should be the impetus for further scholarship and debate about how psychedelic research and therapies can be made accessible to members of disability communities who might benefit. Frontiers Media S.A. 2022-05-25 /pmc/articles/PMC9174510/ /pubmed/35693959 http://dx.doi.org/10.3389/fpsyt.2022.914458 Text en Copyright © 2022 Mintz, Gammer, Khan, Shaub, Levine and Sisti. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Mintz, Kevin T. Gammer, Brinn Khan, Amanda J. Shaub, Gretchen Levine, Steven Sisti, Dominic Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice |
title | Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice |
title_full | Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice |
title_fullStr | Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice |
title_full_unstemmed | Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice |
title_short | Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice |
title_sort | physical disability and psychedelic therapies: an agenda for inclusive research and practice |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174510/ https://www.ncbi.nlm.nih.gov/pubmed/35693959 http://dx.doi.org/10.3389/fpsyt.2022.914458 |
work_keys_str_mv | AT mintzkevint physicaldisabilityandpsychedelictherapiesanagendaforinclusiveresearchandpractice AT gammerbrinn physicaldisabilityandpsychedelictherapiesanagendaforinclusiveresearchandpractice AT khanamandaj physicaldisabilityandpsychedelictherapiesanagendaforinclusiveresearchandpractice AT shaubgretchen physicaldisabilityandpsychedelictherapiesanagendaforinclusiveresearchandpractice AT levinesteven physicaldisabilityandpsychedelictherapiesanagendaforinclusiveresearchandpractice AT sistidominic physicaldisabilityandpsychedelictherapiesanagendaforinclusiveresearchandpractice |